Sickle cell disease could soon be treated with cutting-edge gene therapies. But depending on their price, it could be difficult for state Medicaid programs and patients to afford them.
Sickle cell disease could soon be treated with cutting-edge gene therapies. But depending on their price, it could be difficult for state Medicaid programs and patients to afford them.